liraglutide and Body-Weight

liraglutide has been researched along with Body-Weight* in 1 studies

Other Studies

1 other study(ies) available for liraglutide and Body-Weight

Article	Year
Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties. Bioorganic & medicinal chemistry, 2019, 10-15, Volume: 27, Issue:20 Exenatide is known as the first marketed GLP-1 agonist for antidiabetic treatment, but it need twice injection a day because of its fast clearance. This work aims to prolong the half-life of exenatide by modified with novel lipid chain. Four optimized exenatide analogs named as Cys12-Exenatide (1-39)-NH Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Exenatide; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Hypoglycemic Agents; Lipids; Male; Mice; Mice, Inbred Strains; Mice, Obese; Molecular Structure; Rats; Rats, Sprague-Dawley; Streptozocin; Structure-Activity Relationship	2019

Article

Year

Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties.

Bioorganic & medicinal chemistry, 2019, 10-15, Volume: 27, Issue:20

Exenatide is known as the first marketed GLP-1 agonist for antidiabetic treatment, but it need twice injection a day because of its fast clearance. This work aims to prolong the half-life of exenatide by modified with novel lipid chain. Four optimized exenatide analogs named as Cys12-Exenatide (1-39)-NH

Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Exenatide; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Hypoglycemic Agents; Lipids; Male; Mice; Mice, Inbred Strains; Mice, Obese; Molecular Structure; Rats; Rats, Sprague-Dawley; Streptozocin; Structure-Activity Relationship

2019